- Variant
- Cagrilintide + Semaglutide 5 mg + 5 mg
- Batch #
- CS10-260810
- Labeled
- 5 mg + 5 mg
- Actual
- 10.21 mg
- Tested
- Aug 3, 2026
Genesis Biolabs · COA #1542747 · verify

A two-component research blend supplied as a single lyophilized vial containing 5 mg each of Cagrilintide, a long-acting acylated analog of the peptide hormone amylin, and Semaglutide, a 31-amino-acid analog of the GLP-1 backbone. Third-party tested to 99%+ HPLC purity and supplied for laboratory study of receptor pharmacology and metabolic signaling pathways — research use only, not for human or veterinary use.
Supplied lyophilized — requires BAC waterReview the published certificate for each listed strength, including its batch number and reported purity, potency, identity, heavy metals, sterility and endotoxin results.
Research compounds our customers frequently order alongside this one.
Technical specifications
Each component is individually third-party tested; see the Certificate of Analysis above.
Research-grade peptides with published lab documentation, fast shipping, and dedicated research support.


Lyophilized (powder)
-20°C · up to 2 years
Reconstituted
2-8°C · up to 30 days